Recently, a recurrent heterozygous dominant negative de novo mutation in TCF3 (Transcription Factor 3) gene (OMIM*147141) was identified in four unrelated patients presenting with autosoHomozygous TCF3 mutation is associated with severe hypogammaglobulinemia andB-cell acute lymphoblastic leukemiamal dominant agammaglobulinemia.